Targeting mutant-p53 for cancer treatment: Are we there yet?

Targeting mutant-p53 for cancer treatment: Are we there yet?

Background: Mutations in the TP53 gene are the most common among genetic alterations in human cancers, resulting in the formation of mutant p53 protein (mutp53). Mutp53 promotes proliferation, migration, invasion, and metastasis in cancer cells. Not only does the initiation of oncogenesis ensue due...

Full description

Saved in:
Bibliographic Details
Main Authors: Lim, Dhi Vya, Woo, Wei Hwei, Lim, Jing Xuan, Loh, Xin Yee, Soh, Hui Ting, Lim, Seng Yung Adrian, Lee, Zheng Yang, Yow, Hui Yin, Hamzah, Sharina Binti, Sellappans, Renukha, Foo, Jhi Biau
Format: Article
Published: Bentham Science Publishers 2024
Subjects:
R Medicine
RM Therapeutics. Pharmacology
Online Access:http://eprints.um.edu.my/44987/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya

Internet

http://eprints.um.edu.my/44987/

Similar Items